1820 SKIN CLINIC AS: årsregnskap 2024 vs 2023
Grew 56% on revenue, returned to profit, cash halved-plus
registry 2025-04-26; journal 2025 388943
Summary
What changed
Comparing Årsregnskap 2024 with 2023 for 1820 SKIN CLINIC AS. Revenue 794.8k NOK → 1.24m NOK (+55.6%). Net result -118.3k NOK → +45.3k NOK. Equity -217.1k NOK → -171.8k NOK.
On the constructive side: revenue rose; operating result improved; turned profitable. Pressures included: cash fell.
Also worth watching: thin equity buffer; cogs fell. All figures are taken from the published annual accounts for 1820 SKIN CLINIC AS.
At a glance
Scorecard
What improved
-
↑
Revenue rose
Operating income / revenue moved from 794.8k NOK to 1.24m NOK (+55.6% YoY). Calculated
-
↑
Operating result improved
Operating result -98.3k NOK → +72.6k NOK (op. margin -12.4% → 5.9%). Calculated
-
↑
Turned profitable
Net result flipped from a loss of 118.3k NOK to a profit of 45.3k NOK. Calculated
-
↑
Equity strengthened
Book equity -217.1k NOK → -171.8k NOK (equity ratio -69.1% → -81.7%). Calculated
-
↑
Payroll decreased
Salary cost 797.4k NOK → 266.2k NOK (100% → 22% of revenue). Calculated
What deteriorated
-
↓
Cash fell
Bank deposits 84.2k NOK → 39.5k NOK (-53.1% YoY). Calculated
Things to notice
-
·
Thin equity buffer
Equity ratio is -81.7% of assets — limited loss-absorbing capacity on a stand-alone basis. Interpretation
-
·
COGS fell
COGS / varekostnad 571.5k NOK → 355.6k NOK (-37.8% YoY). Calculated